Yigal Nochomovitz
Stock Analyst at Citi
(4.75)
# 629
Out of 4,504 analysts
739
Total ratings
49.3%
Success rate
15.3%
Average return
Main Sectors:
Stocks Rated by Yigal Nochomovitz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZYME Zymeworks | Maintained: Buy | $35 → $37 | $25.88 | +42.97% | 32 | Jun 30, 2026 | |
| CADL Candel Therapeutics | Maintained: Buy | $26 | $9.49 | +173.97% | 9 | Jun 30, 2026 | |
| ACAD ACADIA Pharmaceuticals | Rated: Buy | $32 → $35 | $26.22 | +33.49% | 7 | Jun 26, 2026 | |
| NBIX Neurocrine Biosciences | Maintained: Buy | $246 | $177.11 | +38.90% | 10 | Jun 15, 2026 | |
| TVTX Travere Therapeutics | Rated: Buy | $62 → $70 | $56.59 | +23.70% | 18 | Jun 14, 2026 | |
| MIRM Mirum Pharmaceuticals | Maintained: Buy | $145 | $122.13 | +18.73% | 2 | Jun 14, 2026 | |
| ONC BeOne Medicines AG | Maintained: Buy | $405 → $453 | $298.70 | +51.66% | 7 | Jun 12, 2026 | |
| BMEA Biomea Fusion | Maintained: Buy | $7 | $1.32 | +430.30% | 19 | Jun 11, 2026 | |
| CRBU Caribou Biosciences | Maintained: Buy | $8 | $1.93 | +315.58% | 22 | Jun 11, 2026 | |
| STTK Shattuck Labs | Rated: Buy | $7 → $18 | $6.64 | +171.08% | 13 | Jun 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $35 | $21.58 | +62.19% | 3 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $14 | $10.42 | +34.36% | 6 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $43 | $33.69 | +27.63% | 13 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $15.25 | +162.30% | 18 | May 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $62 | $11.91 | +420.57% | 13 | May 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $14.56 | +44.23% | 1 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $69 → $81 | $42.55 | +90.36% | 18 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $26 → $20 | $5.59 | +257.78% | 14 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $41 | $28.74 | +42.66% | 11 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2.3 → $3.1 | $2.22 | +39.64% | 33 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $47 → $44 | $20.49 | +114.74% | 27 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $13 | $18.95 | -31.40% | 12 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $80 → $82 | $53.35 | +53.70% | 25 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $33.82 | +33.06% | 29 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $371 → $378 | $365.81 | +3.33% | 11 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $17 → $16 | $10.85 | +47.47% | 19 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $21 → $24 | $8.27 | +190.21% | 24 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $276 → $282 | $316.24 | -10.83% | 3 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $65 | $36.99 | +75.72% | 19 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $7 → $9 | $12.71 | -29.19% | 5 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 → $35 | $14.72 | +137.77% | 2 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $42 | $22.52 | +86.50% | 2 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $44 → $45 | $28.92 | +55.60% | 29 | Mar 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $7 → $8 | $6.97 | +14.78% | 20 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $51 → $57 | $23.61 | +141.42% | 16 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 → $14 | $5.28 | +165.15% | 24 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $1.76 | +468.18% | 7 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $2 → $4 | $1.73 | n/a | 10 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $11 | $2.99 | n/a | 9 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $11 → $8 | $1.54 | n/a | 8 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 → $10 | $0.02695 | n/a | 5 | Sep 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $14 | $4.33 | n/a | 16 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3.5 → $1.2 | $2.52 | n/a | 18 | Jun 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $3.10 | n/a | 11 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $2.07 | n/a | 16 | Dec 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $35 → $10 | $9.76 | n/a | 17 | Nov 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 → $8 | $1.79 | n/a | 4 | Sep 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1.5 → $1 | $1.89 | n/a | 6 | Sep 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $63 | $84.85 | n/a | 1 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 → $2 | $1.34 | n/a | 3 | Nov 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €12.00 | $1.57 | n/a | 1 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $30 → $8 | $51.09 | n/a | 5 | Apr 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $8 → $11 | $8.00 | n/a | 24 | Sep 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $26 → $2 | $0.711 | n/a | 5 | Aug 21, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $9 | $1.40 | n/a | 1 | Mar 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0001 | n/a | 4 | Dec 29, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $0.000001 | n/a | 6 | Aug 13, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $5.53 | n/a | 2 | Apr 27, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 | $6.86 | n/a | 6 | Mar 31, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $49 | $10.20 | n/a | 6 | Mar 30, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $53 | $10.34 | n/a | 5 | Mar 16, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $3.27 | n/a | 1 | Jan 9, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $12.76 | n/a | 3 | Nov 23, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2,124.00 | n/a | 3 | Nov 21, 2014 |
Zymeworks
Jun 30, 2026
Maintained: Buy
Price Target: $35 → $37
Current: $25.88
Upside: +42.97%
Candel Therapeutics
Jun 30, 2026
Maintained: Buy
Price Target: $26
Current: $9.49
Upside: +173.97%
ACADIA Pharmaceuticals
Jun 26, 2026
Rated: Buy
Price Target: $32 → $35
Current: $26.22
Upside: +33.49%
Neurocrine Biosciences
Jun 15, 2026
Maintained: Buy
Price Target: $246
Current: $177.11
Upside: +38.90%
Travere Therapeutics
Jun 14, 2026
Rated: Buy
Price Target: $62 → $70
Current: $56.59
Upside: +23.70%
Mirum Pharmaceuticals
Jun 14, 2026
Maintained: Buy
Price Target: $145
Current: $122.13
Upside: +18.73%
BeOne Medicines AG
Jun 12, 2026
Maintained: Buy
Price Target: $405 → $453
Current: $298.70
Upside: +51.66%
Biomea Fusion
Jun 11, 2026
Maintained: Buy
Price Target: $7
Current: $1.32
Upside: +430.30%
Caribou Biosciences
Jun 11, 2026
Maintained: Buy
Price Target: $8
Current: $1.93
Upside: +315.58%
Shattuck Labs
Jun 9, 2026
Rated: Buy
Price Target: $7 → $18
Current: $6.64
Upside: +171.08%
Jun 8, 2026
Rated: Buy
Price Target: $35
Current: $21.58
Upside: +62.19%
Jun 4, 2026
Rated: Buy
Price Target: $14
Current: $10.42
Upside: +34.36%
Jun 3, 2026
Maintained: Buy
Price Target: $43
Current: $33.69
Upside: +27.63%
May 31, 2026
Maintained: Buy
Price Target: $40
Current: $15.25
Upside: +162.30%
May 31, 2026
Maintained: Buy
Price Target: $62
Current: $11.91
Upside: +420.57%
May 18, 2026
Initiated Coverage: Buy
Price Target: $21
Current: $14.56
Upside: +44.23%
May 13, 2026
Rated: Buy
Price Target: $69 → $81
Current: $42.55
Upside: +90.36%
May 13, 2026
Rated: Buy
Price Target: $26 → $20
Current: $5.59
Upside: +257.78%
May 13, 2026
Reiterated: Buy
Price Target: $41
Current: $28.74
Upside: +42.66%
May 11, 2026
Maintained: Buy
Price Target: $2.3 → $3.1
Current: $2.22
Upside: +39.64%
May 8, 2026
Maintained: Buy
Price Target: $47 → $44
Current: $20.49
Upside: +114.74%
May 6, 2026
Maintained: Sell
Price Target: $13
Current: $18.95
Upside: -31.40%
May 6, 2026
Rated: Buy
Price Target: $80 → $82
Current: $53.35
Upside: +53.70%
May 5, 2026
Maintained: Buy
Price Target: $45
Current: $33.82
Upside: +33.06%
May 5, 2026
Rated: Buy
Price Target: $371 → $378
Current: $365.81
Upside: +3.33%
May 5, 2026
Rated: Buy
Price Target: $17 → $16
Current: $10.85
Upside: +47.47%
May 1, 2026
Rated: Buy
Price Target: $21 → $24
Current: $8.27
Upside: +190.21%
Apr 15, 2026
Rated: Buy
Price Target: $276 → $282
Current: $316.24
Upside: -10.83%
Apr 13, 2026
Maintained: Buy
Price Target: $65
Current: $36.99
Upside: +75.72%
Mar 10, 2026
Rated: Buy
Price Target: $7 → $9
Current: $12.71
Upside: -29.19%
Mar 9, 2026
Maintained: Buy
Price Target: $33 → $35
Current: $14.72
Upside: +137.77%
Mar 9, 2026
Maintained: Buy
Price Target: $42
Current: $22.52
Upside: +86.50%
Mar 5, 2026
Rated: Buy
Price Target: $44 → $45
Current: $28.92
Upside: +55.60%
Mar 4, 2026
Rated: Hold
Price Target: $7 → $8
Current: $6.97
Upside: +14.78%
Mar 2, 2026
Maintained: Buy
Price Target: $51 → $57
Current: $23.61
Upside: +141.42%
Jan 8, 2026
Maintained: Buy
Price Target: $11 → $14
Current: $5.28
Upside: +165.15%
Sep 3, 2025
Maintained: Buy
Price Target: $10
Current: $1.76
Upside: +468.18%
Mar 7, 2025
Upgraded: Buy
Price Target: $2 → $4
Current: $1.73
Upside: n/a
Dec 11, 2024
Maintained: Buy
Price Target: $16 → $11
Current: $2.99
Upside: n/a
Dec 4, 2024
Rated: Buy
Price Target: $11 → $8
Current: $1.54
Upside: n/a
Sep 12, 2024
Maintained: Buy
Price Target: $12 → $10
Current: $0.02695
Upside: n/a
Aug 15, 2024
Maintained: Buy
Price Target: $16 → $14
Current: $4.33
Upside: n/a
Jun 17, 2024
Maintained: Hold
Price Target: $3.5 → $1.2
Current: $2.52
Upside: n/a
May 15, 2024
Maintained: Buy
Price Target: $10
Current: $3.10
Upside: n/a
Dec 4, 2023
Maintained: Buy
Price Target: $8
Current: $2.07
Upside: n/a
Nov 22, 2023
Maintained: Sell
Price Target: $35 → $10
Current: $9.76
Upside: n/a
Sep 18, 2023
Maintained: Buy
Price Target: $12 → $8
Current: $1.79
Upside: n/a
Sep 18, 2023
Maintained: Hold
Price Target: $1.5 → $1
Current: $1.89
Upside: n/a
May 24, 2023
Rated: Buy
Price Target: $63
Current: $84.85
Upside: n/a
Nov 28, 2022
Maintained: Buy
Price Target: $5 → $2
Current: $1.34
Upside: n/a
Sep 16, 2022
Maintained: Buy
Price Target: €12.00
Current: $1.57
Upside: n/a
Apr 5, 2022
Downgraded: Hold
Price Target: $30 → $8
Current: $51.09
Upside: n/a
Sep 27, 2021
Upgraded: Buy
Price Target: $8 → $11
Current: $8.00
Upside: n/a
Aug 21, 2019
Downgraded: Sell
Price Target: $26 → $2
Current: $0.711
Upside: n/a
Mar 20, 2019
Initiated Coverage: Hold
Price Target: $9
Current: $1.40
Upside: n/a
Dec 29, 2016
Downgraded: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Aug 13, 2015
Initiated Coverage: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Apr 27, 2015
Rated: Hold
Price Target: n/a
Current: $5.53
Upside: n/a
Mar 31, 2015
Maintained: Buy
Price Target: $32
Current: $6.86
Upside: n/a
Mar 30, 2015
Reiterated: Buy
Price Target: $49
Current: $10.20
Upside: n/a
Mar 16, 2015
Reiterated: Buy
Price Target: $53
Current: $10.34
Upside: n/a
Jan 9, 2015
Initiated Coverage: Buy
Price Target: $10
Current: $3.27
Upside: n/a
Nov 23, 2014
Rated: Hold
Price Target: n/a
Current: $12.76
Upside: n/a
Nov 21, 2014
Rated: Hold
Price Target: n/a
Current: $2,124.00
Upside: n/a